Company Overview
Snapshot
Founded in January 2023 by Vitalay Fomin and Amit Weiss, Numenos operates with 11–50 employees. The company has raised $5 million across one funding round. In January 2025, Numenos secured seed funding, with TechAviv Founder Partners participating.
Business overview
Numenos is a techbio company specializing in the development of a clinico-genomic foundation model. The company's core technology aims to advance healthcare and life sciences by leveraging advanced computational models. Numenos serves the health tech and life sciences sectors, focusing on innovative solutions within these industries.
Log in to access full profile ›Company Intelligence Q&A
- When was Numenos founded and by whom?
- Numenos was founded in January 2023 by co-founders Vitalay Fomin and Amit Weiss.
- What is Numenos' primary focus?
- Numenos is a techbio company that developed a clinico-genomic foundation model, operating within the Health Tech & Life Sciences sector.
- What was Numenos' most recent funding activity?
- In January 2025, Numenos secured seed funding, with TechAviv Founder Partners participating.
- How much capital has Numenos raised to date?
- Numenos has raised a total of $5 million across one funding round.
- What is the employee count for Numenos?
- Numenos currently has 11–50 employees.